By Steve Usdin
Contributing Editor

WASHINGTON - The House Democratic leadership on Friday released a summary of its health reform bill, which bears a strong resemblance to legislation crafted by California Rep. Pete Stark, but lacks details in areas of critical importance to the biotechnology industry such as price controls on prescription drugs. It sets the stage for political maneuvering in the House and Senate that will determine the outcome of the health care reform effort.